$ZEPP

Zepp Health Corporation to Report First Quarter 2026 Financial Results on June 8, 2026

Zepp Health Corporation (NYSE: ZEPP) said it will release its unaudited first-quarter 2026 financial results on June 8, 2026. The company will host a conference call at 9:30 p.m. ET the same day, with a live webcast and an archived version on its investor site. A telephone replay will be available until June 15, 2026.

Original reporting
Published May 26, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 12:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ZEPP
Neutral
medium confidence
Mentioned
$ZEPP
Relevance
7/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$ZEPPNeutralMed
01

Why it matters

The main tradable element is the upcoming earnings catalyst; without new numbers, the market reaction will likely hinge on reported performance versus expectations and any guidance commentary.

02

Market read

This sets the next earnings-driven volatility window for ZEPP, but provides no new operational or financial information yet.

03

What to watch

Watch for any pre-announcement leaks, changes in analyst estimates ahead of June 8, and whether the company’s prior quarter trends suggest upside/downside risk.

Relevance 7/10Timing: High—earnings call on June 8, 2026 (9:30 p.m. ET) is the next defined event.

Background

Zepp Health announced it will report unaudited first-quarter 2026 financial results and host an earnings call on June 8, 2026.

Company-level read

Ticker impact

$ZEPPNeutralMedium confidence
Context

Zepp Health scheduled its Q1 2026 results for June 8, 2026, setting a near-term catalyst for earnings expectations and guidance read-through.

Expected impact

Moderate pre-earnings volatility; direction will depend on Q1 revenue/margins and any forward guidance released on June 8.

Evidence & confidence

The article contains no financial figures or guidance, but it clearly establishes the earnings call date/time, which typically affects short-term trading and implied volatility.

Market effects

Smart-wearables/health-tech names may see mild sentiment spillover as traders reprice the group’s near-term earnings calendar.

Limited—event is company-specific, though Zepp’s global footprint could influence broader investor attention to consumer health wearables.

Low—no international deal/regulatory development; impact is primarily on ZEPP positioning.

Counterpoint

Because the release is only a scheduling notice, the stock may trade mostly on broader market/sector moves until actual results are published.

Key entities

  • Zepp Health Corporation

    Smart wearables and health technology provider scheduling Q1 2026 earnings release and conference call.

  • June 8, 2026 earnings call

    9:30 p.m. ET conference call time for Q1 2026 results; replay available until June 15, 2026.

Related articles

$HMNMed

Horace Mann Educators Q2 Earnings Call Highlights

Horace Mann (NYSE:HMN) reported Q2 call highlights. Management said auto frequency and severity trends were favorable and liability losses mid-single digits. It cut its full-year catastrophe-loss assumption to about $75M from $90M, while lowering total net investment income outlook to $465M-$475M. Revenue rose 8% YoY; life sales +20%.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.